EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CS Medica AS's enterprise value is kr51.78 Mil.
CS Medica AS's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr4.89 Mil. Therefore, CS Medica AS's EV-to-Revenue for today is 10.60.
The historical rank and industry rank for CS Medica AS's EV-to-Revenue or its related term are showing as below:
XSAT:CSMED'
s EV-to-Revenue Range Over the Past 10 Years
Min: 4.3 Med: 19.97 Max: 107.93
Current: 10.59
During the past 5 years, the highest EV-to-Revenue of CS Medica AS was 107.93. The lowest was 4.30. And the median was 19.97.
XSAT:CSMED's EV-to-Revenue is ranked worse than 82.79% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 3.06
vs XSAT:CSMED: 10.59
As of today (2024-06-19), CS Medica AS's stock price is kr3.29.
CS Medica AS's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.40. Therefore, CS Medica AS's PS Ratio for today is 8.29.
CS Medica AS EV-to-Revenue Historical Data
The historical data trend for CS Medica AS's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CS Medica AS's EV-to-Revenue
For the Medical Devices subindustry, CS Medica AS's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CS Medica AS's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CS Medica AS's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where CS Medica AS's EV-to-Revenue falls into.
CS Medica AS's current Enterprise Value is kr51.78 Mil.
CS Medica AS's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.89 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CS Medica AS (XSAT:CSMED) EV-to-Revenue Explanation
CS Medica AS's share price for today is kr3.29.
CS Medica AS's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.40.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CS Medica AS EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of CS Medica AS's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSAT:CSMED has been successfully added to your 